Literature DB >> 3104988

Factor VIII structure and proteolytic processing.

D L Eaton, G A Vehar.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3104988

Source DB:  PubMed          Journal:  Prog Hemost Thromb        ISSN: 0362-6350


× No keyword cloud information.
  6 in total

1.  Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.

Authors:  J Ware; J R Toomey; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.

Authors:  B C Lubahn; H M Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Screening for nonsense mutations in patients with severe hemophilia A can provide rapid, direct carrier detection.

Authors:  A P Reiner; A R Thompson
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

4.  Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli.

Authors:  D Scandella; S DeGraaf Mahoney; M Mattingly; D Roeder; L Timmons; C A Fulcher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.

Authors:  P A Foster; C A Fulcher; R A Houghten; S de Graaf Mahoney; T S Zimmerman
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.

Authors:  Behnaz Pezeshkpoor; Ursula Schreck; Arijit Biswas; Julia Driesen; Ann-Cristin Berkemeier; Anna Pavlova; Jens Müller; Johannes Oldenburg
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.